Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded

September 2, 2009 10:14 AM EDT

UPGRADES:
Goldman Sachs upgraded Textron (NYSE: TXT) from Neutral to Buy and added the stock to their Conviction Buy List. The firm set a $23 price target, representing 48% upside.

Citi upgrades Cooper Industries (NYSE: CBE) from Hold to Buy. Price target increased from $37 to $40.

UBS upgrades Siemens AG (NYSE: SI) from Sell to Neutral.

RBC Capital upgrades VeriFone (NYSE: PAY) from Underperform to Sector Perform. The firm also raised its price target on the stock from $8 to $13.

JPMorgan upgrades Banco Bradesco ADS (NYSE: BBD) all the way from Underweight to Overweight, also raising its price target from $13 to $21.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES:
Citi downgrades Rockwell Automation (NYSE: ROK) from Hold to Sell, price target $32.

Soleil Securities downgrades General Mills (NYSE: GIS) from Buy to Hold. Price Target $62. Click here to see more color on the downgrade.

Canaccord Adams downgrades Hologic (Nasdaq: HOLX) from Buy to Hold.

An analyst at UBS has downgraded shares of two top homebuilders, D.R. Horton (NYSE: DHI) and Ryland (NYSE: RYL). The firm moved its investment rating on D.R. Horton from Neutral to Sell, maintaining a $10 price target, and its rating on Ryland from Buy to Neutral, maintaining a $24 target.

Oppenheimer downgrades Novavax (Nasdaq: NVAX) from Outperform to Perform. Price target lowered to $6.

For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades

NEW COVERAGE:
BofA/Merrill reinstated coverage on Gilead Sciences (Nasdaq: GILD) at Buy, Amgen (Nasdaq: AMGN) and Celgene (Nasdaq: CELG) at Neutral, and Biogen (Nasdaq: BIIB) at Underperform.

Credit Suisse initiates coverage on Rackspace (NYSE: RAX) with an Outperform rating. Price target $18.

Barrington Research initiates coverage on Rosetta Stone (NYSE: RST) with an Outperform rating. Price target $26.

Jefferies & Co initiates coverage on Fossil (Nasdaq: FOSL) with a Buy rating. Price target $32.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage


Related Categories

Special Reports

Stocks Mentioned

AMGN 56.35

-0.15 -0.27%
Volume: 5,739,370
Track AMGN

BBD 21.19

+0.34 +1.63%
Volume: 11,876,590
Track BBD

BIIB 46.94

+0.02 +0.04%
Volume: 3,450,587
Track BIIB

CBE 42.69

+1.08 +2.60%
Volume: 1,499,857
Track CBE

CELG 55.45

+0.48 +0.87%
Volume: 3,345,030
Track CELG

DHI 10.28

-0.26 -2.47%
Volume: 7,601,724
Track DHI

FOSL 30.85

-0.60 -1.91%
Volume: 1,104,911
Track FOSL

GILD 46.11

-0.45 -0.97%
Volume: 7,272,243
Track GILD

GIS 68.00

-0.10 -0.15%
Volume: 1,676,021
Track GIS

HOLX 14.47

+0.05 +0.35%
Volume: 3,954,736
Track HOLX

NVAX 3.00

+0.00 +0.00%
Volume: 2,703,545
Track NVAX

PAY 13.26

-0.02 -0.15%
Volume: 739,924
Track PAY

RAX 18.51

+0.28 +1.54%
Volume: 904,289
Track RAX

ROK 43.49

-0.02 -0.05%
Volume: 1,333,640
Track ROK

RST 17.63

+0.17 +0.97%
Volume: 436,891
Track RST

RYL 18.31

+0.27 +1.50%
Volume: 1,569,245
Track RYL

SI 98.62

+0.57 +0.58%
Volume: 442,641
Track SI

TXT 20.05

-0.03 -0.15%
Volume: 3,101,862
Track TXT


Related Entities


Add Your Comment